These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31686128)

  • 21. Arginine-vasopressin in severe forms of septic shock.
    Meyer S; Shamdeen G; Gottschling S; Gortner L
    J Pediatr (Rio J); 2007; 83(4):389; author reply 387-8. PubMed ID: 17676247
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of chronic hypertension on time to goal mean arterial pressure and clinical outcomes in critically ill patients with septic shock requiring vasopressors.
    Yeo QM; Hammond DA; Li C; Olsen KM
    J Crit Care; 2019 Feb; 49():143-148. PubMed ID: 30428412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin in the treatment of vasodilatory septic shock.
    Holmes CL; Walley KR
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):275-86. PubMed ID: 18683474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin for septic shock unresponsive to noradrenaline.
    Yunge M; Petros A
    Arch Dis Child; 2000 May; 82(5):388-9. PubMed ID: 10799431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin for vasopressor-dependent septic shock.
    Szumita PM; Enfanto CM; Greenwood B; Wechsler ME
    Am J Health Syst Pharm; 2005 Sep; 62(18):1931-6. PubMed ID: 16141113
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock.
    Fernandes D; Pacheco LK; Sordi R; Scheschowitsch K; Ramos GC; Assreuy J
    Eur J Pharmacol; 2021 Apr; 897():173953. PubMed ID: 33617825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epinephrine impairs splanchnic perfusion in septic shock.
    Gomersall CD; Joynt GM
    Crit Care Med; 1998 Mar; 26(3):620-1. PubMed ID: 9504598
    [No Abstract]   [Full Text] [Related]  

  • 29. Epinephrine impairs splanchnic perfusion in septic shock.
    Ensinger H; Georgieff M
    Crit Care Med; 1998 Mar; 26(3):619-20; author reply 620-1. PubMed ID: 9504597
    [No Abstract]   [Full Text] [Related]  

  • 30. Associations between peripheral perfusion disorders, mean arterial pressure and dose of norepinephrine administrated in the early phase of septic shock.
    Magnin M; Amson H; Vacheron CH; Thiollière F; Piriou V; Junot S; Bonnet Garin JM; Allaouchiche B
    Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1327-1335. PubMed ID: 34133795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde?
    Levy B
    Crit Care Med; 2003 Jun; 31(6):1866-7. PubMed ID: 12794435
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of hypotension in septic shock.
    Stewart JT
    Lancet; 1996 Mar; 347(9001):622-3. PubMed ID: 8596356
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hypotension in septic shock.
    Pastor CM; Morel DR
    Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355
    [No Abstract]   [Full Text] [Related]  

  • 34. Arterial Pressure Response to an Increase in Norepinephrine Varies Depending on the Baseline Norepinephrine Dose in Patients With Septic Shock.
    Bosch NA; Teja B; Law AC; Wunsch H; Walkey AJ
    Chest; 2023 Nov; 164(5):1228-1231. PubMed ID: 37169282
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action and Reaction: The Role of Catecholamine Agonists and Antagonists in Septic Shock.
    Freebairn R
    Crit Care Med; 2015 Sep; 43(9):2039-40. PubMed ID: 26274717
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors of Vasopressin Responsiveness in Critically Ill Adults.
    Allen B; Kram B; Kram S; Schultheis J; Wolf S; Gilstrap D; Shapiro M
    Ann Pharmacother; 2018 Feb; 52(2):126-132. PubMed ID: 28853293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in Myocardial Contractility in Response to Treatment with Norepinephrine in Septic Shock.
    Innocenti F; Palmieri V; Tassinari I; Capretti E; De Paris A; Gianno A; Marchesini A; Montuori M; Pini R
    Am J Respir Crit Care Med; 2021 Aug; 204(3):365-368. PubMed ID: 33945774
    [No Abstract]   [Full Text] [Related]  

  • 39. Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations.
    Der-Nigoghossian C; Hammond DA; Ammar MA
    Ann Pharmacother; 2020 Jul; 54(7):706-714. PubMed ID: 31958982
    [No Abstract]   [Full Text] [Related]  

  • 40. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
    Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
    Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.